Milexes Singapore Biotech launches IPO in Hong Kong to raise HK $ 1 billion

[SINGAPORE] Singapore has launched mirxes Singapore Biotech launched the initial public stock offer.

The cancer diagnosis, which applies to Singapore exchange items (SGX), the 46,62 million shares shares in HK $ 23.30 each time.

Some 41,958,000 shares or 90 percent of IPO offers will be available to international investors while the rest of the public subscriptions in Hong Kong.

The stock is expected to start the trading on May 23.

Mirbalreiate it processiate that includes its net investment from the world offering will be about 880.5 million.

It is intending about half of the net stages for research and development, management of Flowshies’ gastruclies’ gastruclies’ gastruclies. The product is the world’s first approval approved of the world for detective.

About $ 211 million will be forwarded to research and development for the company’s products.

Another 132.1 million dollars will be used to build capabilities at the end of the mirxes’ ability to capture their trade abilities.

$ 88 million in rest of $ 88 million will be used for other companies and companies.

The management of the enterprises have been agreed to the subscriber equivalent to US $ 50 million, can subscribe to the shares of US $ 7.92 million.

China Corp Corp and CCB International is a joint vessel and clergy for IPO.